217 related articles for article (PubMed ID: 26098885)
1. Mutations in the 5' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity.
Massilamany C; Gangaplara A; Basavalingappa RH; Rajasekaran RA; Vu H; Riethoven JJ; Steffen D; Pattnaik AK; Reddy J
PLoS One; 2015; 10(6):e0131052. PubMed ID: 26098885
[TBL] [Abstract][Full Text] [Related]
2. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.
Lee CK; Kono K; Haas E; Kim KS; Drescher KM; Chapman NM; Tracy S
J Gen Virol; 2005 Jan; 86(Pt 1):197-210. PubMed ID: 15604447
[TBL] [Abstract][Full Text] [Related]
4. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
5. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.
Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ
J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991
[TBL] [Abstract][Full Text] [Related]
6. 5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.
Chapman NM; Kim KS; Drescher KM; Oka K; Tracy S
Virology; 2008 Jun; 375(2):480-91. PubMed ID: 18378272
[TBL] [Abstract][Full Text] [Related]
7. Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis.
Willian S; Tracy S; Chapman N; Leser S; Romero J; Shapiro B; Currey K
Arch Virol; 2000; 145(10):2061-86. PubMed ID: 11087092
[TBL] [Abstract][Full Text] [Related]
8. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
9. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
Dunn JJ; Chapman NM; Tracy S; Romero JR
J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of genomic RNA of Coxsackievirus B3 in murine myocarditis: reliability of direct sequencing of reverse transcription-nested polymerase chain reaction products.
Zhang H; Soteriou B; Knowlson S; Theodoridou A; Archard LC
J Virol Methods; 1997 Dec; 69(1-2):7-17. PubMed ID: 9504746
[TBL] [Abstract][Full Text] [Related]
11. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
12. Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3.
Chapman NM; Romero JR; Pallansch MA; Tracy S
J Med Virol; 1997 Jul; 52(3):258-61. PubMed ID: 9210033
[TBL] [Abstract][Full Text] [Related]
13. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
Lee C; Maull E; Chapman N; Tracy S; Gauntt C
J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
[TBL] [Abstract][Full Text] [Related]
14. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
15. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
16. Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model.
Kim YJ; Ahn J; Jeung SY; Kim DS; Na HN; Cho YJ; Yun SH; Jee Y; Jeon ES; Lee H; Nam JH
Virus Genes; 2008 Feb; 36(1):141-6. PubMed ID: 18172750
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence.
Cameron-Wilson CL; Pandolfino YA; Zhang HY; Pozzeto B; Archard LC
Clin Diagn Virol; 1998 Apr; 9(2-3):99-105. PubMed ID: 9645991
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
20. The whole genome sequence of coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis.
Liu B; Li Z; Xiang F; Li F; Zheng Y; Wang G
Virol J; 2014 Feb; 11():33. PubMed ID: 24555514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
